Putting a value on how much an early-stage biotech company is worth is no easy task. Raising money for an early-stage biotech is even harder. But the good news is that last year was a record year for financing in the industry, with a 66 percent increase in VC funding over 2006, according a recently [...]
Filed under: national venture conference | No Comments »
Attendees awoke to the news this morning about GlaxoSmithKline’s announcement that it will pay millions — $720 million to be exact — for Sirtris Pharmaceuticals. This is the stuff biotech CEOs dream about. And it was the buzz at many breakfast tables at this morning’s workshop, “Antibiotics: Bad Bugs – Few Drugs.”
The BNVC meeting, of [...]
Filed under: national venture conference | Tagged: BIO, biotechnology, Biotechnology Industry Organization, national venture conference, venture funding | No Comments »
More than 60 company presentations are scheduled to take place between today and tomorrow. Whether you sat in on Optherion, Colby Pharmaceutical, or another presentation, chances are the session was jammed pack. Each presenter was allotted 15 minutes to make the case for why his or her company is the company to invest in. – [...]
Filed under: national venture conference | No Comments »
While the economy may not be as robust as it has in recent years, there certainly was no sign of that at today’s Opening Luncheon. Jim Greenwood, our President & CEO welcomed attendees to the inaugural BIO National Venture Conference and cited these impressive stats:
140 top-level (VP and higher) venture capitalists – including 4 international investors – [...]
Filed under: national venture conference | Tagged: BIO, biotechnology, Biotechnology Industry Organization, national venture conference, nvc, venture funding | No Comments »
The marathon may be over, but that doesn’t mean there isn’t plenty more activity going on here in Boston. We’re here in Cambridge, one of biotechnology’s “hot-spots” for the inaugural BIO National Venture Conference meeting up with some of the newest early stage and seed stage companies seeking venture funding. Stay tuned for more as the [...]
Filed under: national venture conference | Tagged: BIO, biotechnology, Biotechnology Industry Organization, bnvc, national venture conference, venture funding | No Comments »
….without the fire. But that’s okay since it was in the upper 50s yesterday! A Fireside Chat with Cheryl Scott, chief operating officer for the Bill & Melinda Gates Foundation – what a nice way to end a very productive and informative two days in Reston. And what a pleasant, down-to-earth, and passionate woman who [...]
Filed under: Partnering for Global Health | Tagged: Global Health, BIO Ventures for Global Health, Bill & Melinda Gates Foundation, Cheryl Scott, partnering for global health forum | No Comments »
The afternoon sessions here at PGH really got me thinking about innovation. It’s a word you hear thrown around a lot in biotech – as well as many other areas of science and technology. Actually, it probably gets overused. But when you really think about the word’s true meaning, you realize that innovation is what [...]
Filed under: Partnering for Global Health | Tagged: BIO, BIO Ventures for Global Health, BVGH, Global Health, innovation, Partnering for Global Health, PGH | No Comments »
It occurred to me at lunch today that with all my travels, I need to go on a quest – a quest for the best dessert. For those of you who watch the Today Show, you undoubtedly are familiar with the special segment, “Where in the world is Matt Lauer.” Well, I’m proposing a slightly [...]
Filed under: Partnering for Global Health | No Comments »
“Addressing Global Health from Bench to Beside: Necessary Actions at Each State of the Value Chain” was the topic of today’s luncheon discussion. It was another high-level panel discussion with folks from industry, government and the nonprofit sectors. Two issues in particular that kept resurfacing. One was that the term “bedside” is means much more [...]
Filed under: Partnering for Global Health | Tagged: BIO, biotechnology, Global Health, PGH, BVGH, BIO Ventures for Global Health, Partnering for Global Health | No Comments »
It’s a phrase we’ve all heard a million times, but I found it interesting in the context of today’s panel discussion on diagnostic testing for the developing world.
Dr. Jan Gheuens from the Bill & Melinda Gates Foundation made the comment “The research may be global but the delivery is local.” And when you think about [...]
Filed under: Partnering for Global Health | Tagged: Bill & Melinda Gates, BIO, biotechnology, Gates Foundation, Global Health, Partnership for Global Health, PGH | No Comments »
|
susanatbio
TKtraveler
nicoleatbio
ecreese
sourav123
Jennifer Miller
Darren Fast
christineross
arubenstein
patentbaristas
sdmimi
mikesgene
